Idexx Laboratories LPD — D&A remained flat by 0.0% to $1.01M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.3%, from $950.50K to $1.01M. Over 4 years (FY 2021 to FY 2025), LPD — D&A shows relatively stable performance with a 0.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase often correlates with higher capital expenditure and asset intensity, while a decrease may suggest aging assets or a shift toward asset-light service models.
This represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within t...
Standard operating expense metric used across all capital-intensive industries to assess the cost of maintaining the asset base.
idxx_segment_lpd_depreciation_and_amortization| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $3.91M | $3.80M | $3.66M | $3.80M | $4.04M |
| YoY Change | — | -2.8% | -3.7% | +4.0% | +6.3% |